Australian moths master long-distance migration using starry skies

Canberra: Australian Bogong moths have been shown to use constellations and the Milky Way as a celestial compass to navigate annual migrations of up to 1,000 km, new research has revealed.
The research, led by an international team of scientists, marks the first time an insect has been proven to rely on stellar navigation for long-distance travel, according to a release from the University of South Australia on Thursday.
"Until now, we knew that some birds and even humans could use the stars to navigate long distances, but this is the first time that it's been proven in an insect," said co-author of the study Eric Warrant of Lund University in Sweden who is also a visiting fellow at the Australian National University and an adjunct professor at the University of South Australia.
Each spring, billions of Bogong moths migrate from southeast Australia to hibernate in the Snowy Mountains' alpine caves, returning in autumn to breed. Lab tests confirmed they fly seasonally south in spring and north in autumn using stellar navigation, said the researchers, reported Xinhua news agency.
When the night sky was rotated, the moths reversed direction; when star patterns were scrambled, they lost orientation, confirming their dependence on specific celestial cues, said the study published in Nature.
When clouds obscured stars, the moths switched to Earth's magnetic field, revealing a dual navigation system for reliability. Specialized brain neurons fired strongest when facing south, demonstrating sophisticated tiny-brain navigation, the release said.
The discovery is crucial for conservation, as Bogong moths are now vulnerable; protecting their migratory routes and dark skies is vital, and the findings may inspire advanced navigation technologies, it said.
"It's about how animals read the world around them ... The night sky has guided human explorers for millennia. Now we know that it guides moths, too," said Warrant.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Hans India

12 hours ago

• Hans India

Australian moths master long-distance migration using starry skies

Canberra: Australian Bogong moths have been shown to use constellations and the Milky Way as a celestial compass to navigate annual migrations of up to 1,000 km, new research has revealed. The research, led by an international team of scientists, marks the first time an insect has been proven to rely on stellar navigation for long-distance travel, according to a release from the University of South Australia on Thursday. "Until now, we knew that some birds and even humans could use the stars to navigate long distances, but this is the first time that it's been proven in an insect," said co-author of the study Eric Warrant of Lund University in Sweden who is also a visiting fellow at the Australian National University and an adjunct professor at the University of South Australia. Each spring, billions of Bogong moths migrate from southeast Australia to hibernate in the Snowy Mountains' alpine caves, returning in autumn to breed. Lab tests confirmed they fly seasonally south in spring and north in autumn using stellar navigation, said the researchers, reported Xinhua news agency. When the night sky was rotated, the moths reversed direction; when star patterns were scrambled, they lost orientation, confirming their dependence on specific celestial cues, said the study published in Nature. When clouds obscured stars, the moths switched to Earth's magnetic field, revealing a dual navigation system for reliability. Specialized brain neurons fired strongest when facing south, demonstrating sophisticated tiny-brain navigation, the release said. The discovery is crucial for conservation, as Bogong moths are now vulnerable; protecting their migratory routes and dark skies is vital, and the findings may inspire advanced navigation technologies, it said. "It's about how animals read the world around them ... The night sky has guided human explorers for millennia. Now we know that it guides moths, too," said Warrant.

NDTV

4 days ago

• NDTV

Australian Researchers Develop AI Model That Turns Brainwaves Into Words

Australian scientists are developing an artificial intelligence (AI) system that decodes brainwaves into text, or simply put, thoughts from brainwaves. While doctors use electroencephalogram (EEG) to diagnose brain conditions, researchers at Sydney's University of Technology (UTS) are using it to read thoughts. An AI Model, developed by PhD students Charles (Jinzhao) Zhou and his supervisors Chin-Teng Lin and Dr Leong, uses deep learning to translate the brain signals from EEG into specific words. "I am jumping happily, it's just me," the AI model produced the result when Dr Leong wore the 128-electrode EEG cap and did not utter a single word. Currently, the AI model has been trained on a small set of words and sentences to simplify the process of recognising each word, according to a report in ABC News. The AI is used to filter out noise and clarify the brain signals because signals from different brain sources overlap on the skull's surface, he added. While Elon Musk's Neuralink is known for producing something similar, the research by the Sydney scientists is non-invasive in nature. "We can't get very precise because with non-invasive, you can't actually put it into that part of the brain that decodes words," said Mr Lin. The technology has immense implications for stroke rehabilitation, speech therapy in autism, and restoring communication for paralysis patients. AI and human brain Across the globe, scientists have been combining EEG and AI to produce impressive results. In April, researchers at Mass General Brigham came up with an AI tool capable of predicting brain decline in patients, years in advance. The AI tool analyses subtle changes in brain activity during sleep using EEG to make the prediction. During one of the studies, it correctly flagged 85 per cent of individuals who eventually experienced cognitive decline, with an overall accuracy of 77 per cent.

Hans India

4 days ago

• Hans India

Researchers launch pioneering trial targeting untreatable cancers

New Delhi: Researchers have launched a pioneering clinical trial that aims to combat aggressive cancers previously deemed untreatable. The trial led by a team from the Australian National University (ANU) focussed on malignancies driven by the elusive MYC protein -- a protein implicated in 70 per cent of human cancers --, Xinhua news agency reported. The success of the trial could redefine treatment paradigms for aggressive malignancies globally, offering a template for tackling other molecularly complex diseases, said the team. The study will test an experimental drug, PMR-116, designed to disrupt cancer growth mechanisms in patients with prostate, breast, ovarian, and blood cancers, or MYC-driven tumours. The MYC protein is a key regulator of cell growth. It is often implicated in cancer, contributing to tumour development. Led by the ANU and Canberra Health Services the trial adopts an innovative 'basket' approach, grouping participants based on molecular biomarkers rather than cancer type. This method streamlines research by targeting MYC through its downstream effects, meaning it blocks the processes MYC triggers in the cell rather than trying to block MYC itself, according to the study. PMR-116, developed by ANU researchers and biotech firm Pimera Therapeutics, inhibits ribosomal biogenesis, a cellular process exploited by MYC-driven tumours. 'MYC is one of the most notorious cancer-causing genes, and tumours driven by MYC overexpression are often among the most aggressive and difficult to treat,' said hematologist and ANU professor Mark Polizzotto, who will lead the clinical trial. 'MYC has long been considered 'undruggable,' but early results of PMR-116 show promise in changing that perception,' he added. The trial will enroll patients at major hospitals in Canberra, Melbourne, and Sydney starting in late 2025, prioritising those whose cancers resist standard therapies, said the research team. ANU professor Ross Hannan, co-developer of PMR-116, highlighted that this approach represents a new direction in precision oncology, focusing on cancer's molecular drivers instead of its location, potentially speeding up treatments for many patients worldwide.